TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma

Lancet. 2025 Jan 18;405(10474):174-176. doi: 10.1016/S0140-6736(24)02680-1. Epub 2025 Jan 8.

Authors

Florian P Reiter¹, Andreas Geier²

Affiliations

¹ Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg 97080, Germany. Electronic address: Reiter_F@ukw.de.
² Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg 97080, Germany.

PMID: 39798580
DOI: 10.1016/S0140-6736(24)02680-1

No abstract available

Publication types

Comment